| Original language | English |
|---|---|
| Pages (from-to) | e73-e76 |
| Journal | British Journal of Haematology |
| Volume | 190 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1 Jul 2020 |
Keywords
- BTK inhibitors
- CLL
- COVID-19
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19
- Santiago Thibaud
- , Douglas Tremblay
- , Sheena Bhalla
- , Brittney Zimmerman
- , Keith Sigel
- , Janice Gabrilove
- Icahn School of Medicine at Mount Sinai
- CTSA ConduITS - Institutes for Translational Sciences
- Cancer Prevention & Control
- Graduate School of Biomedical Sciences
- KL2
- Medicine
- Medicine - General Internal Medicine
- Medicine - Infectious Diseases
- Mount Sinai Tisch Cancer Center
- Medicine - Hematology and Medical Oncology
- Oncological Sciences
Research output: Contribution to journal › Letter › peer-review
76
Scopus
citations